When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis

被引:42
|
作者
Prince, F. H. M. [1 ]
Twilt, M. [1 ,2 ]
Simon, S. C. M. [1 ]
van Rossum, M. A. J. [3 ,4 ]
Armbrust, W. [5 ]
Hoppenreijs, E. P. A. H. [6 ]
Kamphuis, S. [1 ]
van Santen-Hoeufft, M. [7 ]
Koopman-Keemink, Y. [8 ]
Wulffraat, N. M. [9 ]
ten Cate, R. [2 ]
van Suijlekom-Smit, L. W. A. [1 ]
机构
[1] Sophia Childrens Univ Hosp, Erasmus MC, Dept Paediat Paediat Rheumatol, NL-3000 CB Rotterdam, Netherlands
[2] Leiden Univ, Med Ctr, Dept Paediat Paediat Rheumatol, Leiden, Netherlands
[3] Emma Childrens Hosp AMC, Dept Paediat Paediat Rheumatol, Amsterdam, Netherlands
[4] Jan van Breemen Inst, Amsterdam, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Paediat Paediat Rheumatol, Groningen, Netherlands
[6] Univ Nijmegen, Med Ctr Radboud, Dept Paediat Paediat Rheumatol, Nijmegen, Netherlands
[7] Maastricht Univ, Med Ctr, Dept Internal Med, Subdiv Rheumatol, Maastricht, Netherlands
[8] Hagaziekenhuis Juliana Childrens Hosp, Dept Paediat, The Hague, Netherlands
[9] Utrecht MC Wilhelmina Childrens Hosp, Dept Paediat Paediat Rheumatol, Utrecht, Netherlands
关键词
CLINICAL REMISSION; SELECT CATEGORIES; REGISTER; CRITERIA;
D O I
10.1136/ard.2008.101030
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1228 / 1229
页数:2
相关论文
共 50 条
  • [21] Successful treatment with tocilizumab of a psoriasiform skin lesion induced by etanercept in a patient with juvenile idiopathic arthritis
    Shimizu, Masaki
    Hamaguchi, Yasuhito
    Ishikawa, Sayaka
    Ueno, Kazuyuki
    Yachie, Akihiro
    MODERN RHEUMATOLOGY, 2015, 25 (06) : 972 - 973
  • [22] Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients
    Southwood, Taunton R.
    Foster, Helen E.
    Davidson, Joyce E.
    Hyrich, Kimme L.
    Cotter, Catherine B.
    Wedderburn, Lucy R.
    Hull, Richard G.
    Venning, Helen E.
    Rahman, Joy K.
    Cummins, Carole L.
    RHEUMATOLOGY, 2011, 50 (01) : 189 - 195
  • [23] Bone mineral density improvement after one year of treatment with etanercept in patients with juvenile idiopathic arthritis
    G Susic
    R Stojanovic
    N Damjanov
    J Vojinovic
    G Vijatov
    Pediatric Rheumatology, 6 (Suppl 1)
  • [24] Experience in the treatment with etanercept in patients with juvenile idiopathic arthritis under 4 years
    Calvo, I.
    Lopez, B.
    Marco, A.
    Maneiro, J. R.
    Diez, C.
    Espino-Lorenzo, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 387 - 387
  • [25] Clinical remission in juvenile idiopathic arthritis after termination of etanercept
    Postepski, Jacek
    Kobusinska, Katarzyna
    Olesinska, Edyta
    Osinska, Violetta
    Opoka-Winiarska, Violetta
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (10) : 2657 - 2660
  • [26] Clinical remission in juvenile idiopathic arthritis after termination of etanercept
    Jacek Postępski
    Katarzyna Kobusińska
    Edyta Olesińska
    Violetta Osińska
    Violetta Opoka-Winiarska
    Rheumatology International, 2013, 33 : 2657 - 2660
  • [28] Etanercept in systemic juvenile idiopathic arthritis
    Russo, RAG
    Katsicas, MM
    Zelazko, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (05) : 723 - 726
  • [29] An analysis of the costs and treatment success of etanercept in Juvenile Idiopathic Arthritis
    Prince, Femke H. M.
    de Bekker-Grob, Esther W.
    Twilt, Marinka
    van Rossum, Marion A. J.
    Hoppenreijs, Esther P. A. H.
    ten Cate, Rebecca
    Koopman-Keemink, Yvonne
    Gorter, Simone
    Raat, Hein
    van Suijlekom-Smit, Lisette W. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 443 - 443
  • [30] The German etanercept registry for treatment of juvenile idiopathic arthritis.
    Horneff, G
    Biedermann, T
    Foeldvari, I
    Kuesters, RM
    Michels, H
    Moebius, D
    Schmeling, H
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S482 - S482